Euan Angus Ashley
Co-Founder and Member of Clinical & Scientific Advisory BoardDr. Euan Angus Ashley, MB CHB, M.D., Ph.D., FRCP, DPHIL, serves as an Independent Director at DexCom, Inc. since October 24, 2025. Dr. Ashley serves as Member of Scientific Advisory Board at Pacific Biosciences of California, Inc. since November 2022. Dr. Ashley was Member of Scientific Advisory Board of Medical Excellence Capital, LLC until August 2025. Dr. Ashley was employed at Medical Excellence Capital, LLC until August 2025. Dr. Ashley, is the Founder, Chairman of the Board & COB of Silicon Valley Exercise Analytics Inc. He has been a Member of Scientific Advisory Board at Deepcell, Inc. He serves as an Independent Non-Executive Director at AstraZeneca PLC since October 1, 2020. He is a Co-Founder of Personalis, Inc. and serves as its Member of Clinical & Scientific Advisory Board. Dr. Ashley served as a Member of Medical Scientific Advisory Board at Genome Medical, Inc. Dr. Ashley was a Director of Deepcell, Inc. Before moving to Stanford University where he was a Donald W. Reynolds Fellow. He trained in clinical cardiology and advanced heart failure and joined the faculty in 2006. His laboratory is focused on the application of genomics to medicine. In 2010, he led the team that carried out the first clinical interpretation of a human genome. Dr. Ashley was the first co-chair of the steering committee of the Undiagnosed Diseases Network. Dr. Ashley is part of the winning team of the 75m One Brave Idea competition and co-founder of SVExa Inc. In 2013, Dr. Ashley was recognized at the White House Data to Knowledge to Action event for his contributions to Personalized Medicine. He is Associate Dean and Professor of Cardiovascular Medicine and Genetics at Stanford University in California. In addition to wet bench science, his laboratory leverages artificial intelligence and digital health tools, working with biotechnology and technology partners in Silicon Valley, to advance both translational and clinical research. Dr. Ashley is a recipient of the National Innovation Award from the American Heart Association and a National Institutes of Health Director’s New Innovator Award. He is a member of the AHA Council on Functional Genomics and the Institute of Medicine (IOM) of the National Academy of Sciences Roundtable on Translating Genomic-Based Research for Health. He is a peer reviewer for the NIH and the AHA as well as journals including the New England Journal of Medicine and the Lancet. Dr. Ashley has received many awards including recognition from the Obama White House for contributions to personalized medicine and the American Heart Association's Medal of Honor for precision medicine. In 2021, his first book The Genome Odyssey – Medical Mysteries and the Incredible Quest to Solve Them was released. Fellowship in University of Oxford of UK (2002), Internship in University of Glasgow at Scotland, UK (1997) and received a Bachelor’s degree in physiology and medicine at Glasgow University Scotland in UK (1996), a Doctor of Medicine from the University of Glasgow and received a PhD in molecular cardiology at the University of Oxford, he moved to Stanford University to train in cardiology and advanced heart failure.
Positions
- Company NamePersonalis, Inc.Stock CodePSNLPositionCo-Founder and Member of Clinical & Scientific Advisory BoardColleagues
- CMChristopher M. HallCEO & Director
- KEKarin EasthamIndependent Chair of the Board
- RCRichard ChenPresident & Chief Medical Officer
- ALAaron L. TachibanaCFO & COO
- RBRuss B. AltmanCo-Founder and Member of Clinical & Scientific Advisory Board
- MPMichael P. SnyderCo-Founder and Member of Clinical & Scientific Advisory Board
